This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Biologic Excipients Market

Market Insights on Biologic Excipients covering sales outlook, demand forecast & up-to-date key trends

Biologic Excipients Market by Excipients Type (Polymers, Sugar Alcohols, Polysorbates, Inorganic Salts, Amino Acids, Surfactants and Others) & Region for 2022-2028

Biologic Excipients Market Snapshot

[347 Pages Report] The global Biologic Excipients Market was valued US$ 1.3 Bn in 2021 and is expected to reach US$ 1.7 Bn by 2028, reflecting a cumulative CAGR of 3.4% over the forecast period (2022-2028) according to Future Market Insights (FMI) study.

Data Points

Market Insights

Market Value 2022

USD 1.4 Bn

Market Value  2028

USD 1.7 Bn

CAGR 2022 - 2028

3.4%

Top 5 Countries % Share

61.1%

Key Players

The key players in the Biologic Excipients market includes BASF Corporation, FMC Corporation, Wacker Chemie AG, Evonik Industries AG, Ashland Global Holdings Inc., Archer-Daniels-Midland Co., Roquette Freres S.A., The Dow Chemical Company, Colorcon Inc., Signet Chemical Co. Pvt. Ltd.

The biologic excipients market is expanding due to rising demand for extended-release or sustained-release formulations and increasing demand for biologic excipients. Excipients are basically the small molecules that play an important role in the production of biologic drugs. Initiating mass manufacturing of biologic excipients for pharmaceutical purposes has been a crucial milestone in unlocking the potential for manufacturing pharmaceutical grade excipients to be employed in creating biologics.

Patent expiries has been pushing demand for functional excipients in the generics and biologics industry in large volumes. Product testing and manufacturing of novel biologics and biosimilars before a blockbuster patent expires is expected to fuel the requirement for biologic excipients globally. However, majority of testing and manufacturing of biologics is being outsourced to countries including China, India, and Brazil with good infrastructure and cheaper labor costs. As a result, the demand for biologic excipients in these countries is expected to increase significantly over the forecast period.

Demand for oral solid drug formulations has been witnessing steady increase over the past five years owing to ease of consumption by patient classes, including children. Oral dosage forms generally require more amount of excipients than other forms during the drug manufacturing process and is being promoted due to adoption of increased patient-centricity approaches by drug manufacturers

For example, over 50% of patients find it difficult to swallow conventional hard solid tablets. This has prompted drug companies to devise more innovative solid oral product forms such as orally disintegrating granules (ODGs), effervescent tablets, lozenges, instant drinks, and chewable tablets. This is expected to create substantial demand for excipients in the near future.

Drug manufacturers are gradually increasing outsourcing of their excipient R&D to CROs in order to enable significant cost savings. Outsourcing is being done either through full acquisition of CROs or by entering into long-term R&D contracts spanning in the forecast period.

Customize this Report

Let us know your requirement to get
100% FREE customization

How The Market Progressed Till June 2022?

Particulars

Details

H1 - 2021

3.63%

H1 – 2022 Projected

3.38%

H1 – 2022 Outlook

3.28%

BPS Change - H1, 2022 (O) – H1, 2022 (P)

(-) 10 ↓

BPS Change– H1, 2022 (O) – H1, 2021

(-) 35 ↓

FMI presents a comparative analysis about the market growth rates and development prospects in the global biologic excipients market. The market is subject to influence by regulatory approvals and innovation factors in accordance with impact of macro and industry factors. Key developments in this market include developments in value chain, technological advancements, and expansion of R&D facilities.

According to Future Market Insight analysis, the biologic excipients market will drop by 35 Basis Point Share (BPS) in H1-2022 (O) as compared to H1-2021. The variation between the BPS values observed within this market in H1, 2022 - Outlook over H1, 2022 Projected reflects a decline of 10 BPS units.

Major reasons for this drop in BPS is attributed to the fact that emerging players do not adhere to International Pharmaceutical Excipients Council (IPEC) guidelines. Top players like Pfizer once could have incurred huge losses if they were subjected to strict audits back in the day.

In China, there have been instances where emerging players were facing issues in control over supply chain, data management, which conferred to product wastage and redundancy. Other market segments are expected to perform fairly and attain promising growth prospects in the next half of projection period.

Despite the factors, there are some plus points that stay ahead for the industry including demand for multi-functional biologic excipients, greater focus on the sustained release mechanism for biologics and emerging players entering into supply and distributor partnerships to expand their market reach.

2016-2021 Biologic Excipients Market Demand Outlook Compared to 2022 - 2028 Forecast

According to Future Market Insights (FMI), the biologic excipients value is US$ 1.3 Bn in 2021.

In 2021, the global market of biologic excipients accounts for approx. 17% of the overall pharmaceutical excipients market that was valued for around US$ 7.9 Bn.

The biologic excipients market is expected to grow at a strong pace in the forecast period. This is due to excipients' widespread use in the development of new therapies, as well as their capacity to improve the solubility of active pharmaceutical substances, among other things. Furthermore, the continuous evolution of drug delivery technology and the high frequency of autoimmune and inflammatory conditions are two major reasons that are expected to boost the biologic excipients market growth in the forecast period.

Increasing innovative collaborative research opportunities in pediatric formulations is being pushed through evolution of new regulations, additional funding opportunities, and increased public-private partnerships. This has been shifting focus to development of biologic excipients used in both oral solid and liquid pediatric formulations, which are flexible, dispersible and multi-functional.  Furthermore, continued prioritization of unmet medical needs in pediatrics is expected to drive demand for these excipients and oral formulations in the forthcoming years

Biologic Excipients Market Download Report Brochure

Sustained and extended release formulations are gaining popularity as they help in maintaining patient-safety through reduced number of medicine dosages, but having increased drug efficacy. From a commercial point of view, reduced dosing frequency improves treatment compliance, which could translate into higher unit sales and thus revenues. Furthermore, from the patient point of view, better therapeutic outcomes are expected due to improved drug tolerance and efficacy leading to lower switching costs and greater physician loyalty.

Over the past few years, development of sustained-release form of original drugs has gained traction in order to extend patent protection of biologic drugs. When compared with other biologic excipients, polymers offer long term delivery of injectable medicine. However, a new trend of combining sustained-release technology with targeted drug delivery allows to minimize systemic toxicity.

The market is fragmented and is dominated by players such as include, FMC Corporation , Wacker Chemie AG, Evonik Industries AG, Ashland Global Holdings Inc., Archer-Daniels-Midland Co., Roquette Freres S.A., The Dow Chemical Company, Colorcon Inc., Signet Chemical Co. Pvt. Ltd.

Future Market Insights expects the global biologic excipients market to grow at a CAGR of 3.4% by the end of 2028.

How is advanced drug delivery technologies boosting the Biologic Excipients Markets?

The ability of biologic excipients to offer increased efficacy of biologics through enhancement of solubility and bioavailability, enabling controlled/sustained release delivery performance coupled with introduction of innovative technologies focused to target pediatric and geriatric patient populations has made biologic excipients a key preference for biologic drug manufacturers. For instance, use of nanotechnology to manufacture biologic drugs is a recent trend that showcases the technological innovation in development of biologics.

Over the past few years, nanotechnology has been increasingly used in pharmaceutical industry owing to the fact that it improves API solubility, drug’s stability, and also enhances the pharmacological activity of drug with targeted delivery. Thus, with the emergence of such technologies, pharma manufacturers are focused to develop new techniques that enhances the capability of excipients.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are the Key Opportunities for Market Players?

Increasing Demand for multi-functional biologic excipients have been the window for investments as companies are expected to benefit from increased production of multi-functional excipients as these type of excipients enhances the formulation design. They help in generating sustained cost-savings throughout the drug production period.

Companies are expected to benefit from entering into contractual agreements with single distribution partners in emerging markets, along with strong local market knowledge. These economies, particularly India, China, and Brazil exhibit greater demand for healthcare services and products owing to increase in disposable income levels in these countries.

Additionally, Industry experts have noted that greater focus on innovations related to formulation of sustained-release small molecule drugs could provide potential revenue-generating opportunity for excipient manufacturers in the forecast period.

What is the Impact of the COVID-19 Crisis on the Market?

The pharma sector was severely impacted by the COVID-19 epidemic. The supply of raw materials from manufacturing hubs was interrupted by the lockdowns implemented in the wake of the epidemic. This hindered drug development and production, wreaking havoc on businesses that rely largely on outsourcing. Initially, the entire pharmaceutical ecosystem was thrown into disarray. Furthermore, regulatory authorities had to rethink and create new regulations in order to assure maximum patient safety following drug administration.

The pharmaceutical business gained traction once the lockdowns ended, owing to high demand for medications like hydroxychloroquine and Remdesivir, which showed promising effectiveness against COVID-19.

Excipients were critical in ensuring the safety and efficacy of medicines. Some companies saw revenue increase as a result of rising demand for certain drugs. For Instance, in March 31, 2020  excipientworld.org said that the excipients were the initials of drug formulation and during the pandemic, purified water has been the most vital excipients in formulating vaccines to fight COVID-19.

In the coming years, discoveries like these are expected to have a favorable impact on the biologic excipients business.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Country-wise Insights

Will the U.S. Remain a Key Market for Biologic Excipients Markets?

In 2022, the U.S. is estimated to account for nearly 89.0 % value share in North America owing to existence of developed regulations and superior healthcare infrastructure.

Additionally, the demand is increasing in the U.S due to the increasing use of generic drugs that focus on delivering the highest quality and instant care to the patients in the industrial market in North America.

Why is Germany Considered a More Lucrative Market within Europe?

In 2022, Germany is expected to account for nearly 32.9%of the market in Europe. The rise in demand for the biologic excipients market is primarily due to the increasing aging population and chronic diseases, presence of well-established centers which provide quality care. Furthermore, favorable regulatory scenarios and increasing investments for the development of biologics and advanced dosage forms, will increase the demand for novel excipients in Germany market.

What are the Factors Supporting Biologic Excipients Market Sales in China?

The China market is expected to account for around 2.1% market revenue share in 2022 of the global biologic excipients market. The increase in research and development and availability of the medicine to treat symptoms instantly, expansion of the healthcare industry, and the rising need for efficient and safe healthcare practice and other therapeutics are the major factors driving the growth in China.

China also includes domestic market impact factors, regulatory change, favorable government policies and growing funding which affects current and future market trends.

Category-wise Insights

What is the Biologic Excipients Market value?

The market is expected to grow from US$ 1.3 Bn in 2021 to US$ 1.7 Bn in 2028, with a CAGR of around 3.4% over the forecast period (2022 - 2028).

Why the demand for polymers excipients is increasing?

In terms of product type-polymer excipients are anticipated to lead the biologic excipients market over the forecast period. The biologic segment holds the maximum share of 30.1% in 2021, expanding at 3.4% CAGR during the forecast period due to its availability at less cost as compared with other biologic excipients.

Additionally, polymers has been playing very important role in drug delivery systems by providing controlled release of therapeutic agents in constant doses over long periods.

Which segment accounts for the highest market share by end user?

By End User, biopharmaceutical manufacturer’s account for 65.5% and contract research organizations/contract manufacturing organizations accounts for 33.1% of the market share in 2021. These segments are expected to account for a relatively higher revenue share due to rising demand for biologic excipients with various combinations to provide stability and quality control for drug, and harnessing new scientific advances.

Competitive Landscape

Companies operating in the biologic excipients market are actively seeking to strengthen their position through acquisition and partnerships with established as well as emerging market players. The manufacturers have been prompting local drug makers to manufacture excipients in bulk at local facilities and supply them to biologic drug makers at very competitive prices.

Ensuring superior product quality and adherence to good manufacturing and ethical distribution practices are attributes followed diligently by branded drug makers for differentiating themselves to capitalize on the market share and capture the significant share of the market. Some of the recent instances include:

In November 2017, the company entered into partnership with DIEM Labs, to offer U.S. medical food product for the dietary management patients with Non-Alcoholic Fatty Liver Diseases (NAFLD).

On January 31, 2020, BASF closed the acquisition of Solvay’s polyamide business.

Leading industry players are focusing on the development of biologic excipients. Adoption of IPEC guidelines in both manufacturing and distribution is expected to propel adherence to measures, thus enhancing product safety and drug efficacy.

Scope Of The Report

Attribute

Details

Forecast Period

2022 – 2028

Historical Data Available for

2013-2021

Market Analysis

USD Million for Value.

Key Countries Covered

US, Canada, Germany, U.K., France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, South Africa

Key Segments Covered

Excipients Type, End Users  and Region

Key Companies Profiled

  • FMC Corporation
  • Wacker Chemie AG
  • Evonik Industries AG
  • Ashland Global Holdings Inc.,
  •  Archer-Daniels-Midland Co.,
  •  Roquette Freres S.A.,
  • The Dow Chemical Company,
  • Colorcon Inc.,
  • Signet Chemical Co. Pvt. Ltd.
  • Sun Pharmaceutical Industries Ltd,

Report Coverage

Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Biologic Excipients Market by Category

Excipient Type:

  • Polymers
  • Sugar Alcohols
  • Polysorbates
  • Inorganic Salts
  • Amino Acids
  • Surfactants
  • Others

By End User:

  • Biopharmaceutical Manufacturers
  • Contract Research Organizations/Contract Manufacturing Organizations
  • Research Organizations

Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APECJ
  • Middle East & Africa
  • Japan

Frequently Asked Questions

The global biologic excipients market is projected to reflect high demand in the forecast period with a CAGR of 3.4% owing to the increasing technological advancements in drug delivery systems.

North America is expected to account for 44.9% of the global market share in the biologic excipients market with the U.S. being the leading contributor with a market value over US$ 558.4 Mn in 2022

The biologic excipients market in Japan is likely to grow at a CAGR of 2.7% during the forecast period, with a market share of around 1.2% in 2022.

Greater uptake of biologics driving demand for parenteral formulation, increasing acquisition of Contract Research Organizations (CROs) and patent-expiration of major blockbuster drugs have been the factors driving the biologic excipients market.

U.S., India, France, Canada, Germany are the top 5 countries that are driving the demand for the biologic excipients market.

Leading companies of biologic excipients market are BASF Corporation, FMC Corporation, Wacker Chemie AG, Evonik Industries AG, Ashland Global Holdings Inc., Archer-Daniels-Midland Co., Roquette Freres S.A., The Dow Chemical Company, Colorcon Inc., and Signet Chemical Co. Pvt. Ltd.

Table of Content

1. Executive Summary

    1.1. Market Overview

    1.2. Market Analysis

    1.3. FMI Analysis and Recommendations

    1.4. Wheel of Fortune

2. Market Introduction

    2.1. Market Taxonomy

    2.2. Market Definition

3. Biologic Excipients Market Opportunity Analysis 

    3.1. Macro-Economic Factors

    3.2. Opportunity Analysis

4. Global Economic Outlook

    4.1. Global Gross Domestic Product by Region & Country

    4.2. Biologic Excipients Market Outlook

5. Market Background

    5.1. List of Growth Hacking Manufacturers

    5.2. Market Dynamics

        5.2.1. Drivers

            5.2.1.1. Supply Side Drivers

            5.2.1.2. Demand Side Drivers

        5.2.2. Restraints

6. Macroeconomic Assumptions

7. Global Economic Outlook

    7.1. Gross Domestic Product by Region & Country, 2006 – 2021

8. Global Supply Demand Analysis

9. Key Inclusions

    9.1. Key Competitors

    9.2. Usage Trend In Biologic Excipients Industry

10. North America Biologic Excipients Market Analysis 2013-2021 and Forecast 2022–2028

    10.1. Introduction

    10.2. Regional Market Trends

    10.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021

        10.3.1. U.S.

        10.3.2. Canada

    10.4. Market Size (US$ Mn) Forecast By Country, 2022–2028

        10.4.1. U.S.

        10.4.2. Canada

    10.5. Historical Market Size (US$ Mn) & Trend Analysis By Excipient Type, 2013-2021

        10.5.1. Polymers

        10.5.2. Sugar Alcohols

        10.5.3. Polysorbates

        10.5.4. Inorganic Salts

        10.5.5. Amino Acids

        10.5.6. Surfactants

        10.5.7. Others

    10.6. Market Size (US$ Mn) & Forecast By Excipient Type, 2022–2028

    10.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021

        10.7.1. Biopharmaceutical Manufacturers

        10.7.2. Contract Research Organizations/Contract Manufacturing Organizations

        10.7.3. Research Organizations

    10.8. Market Size (US$ Mn) Forecast By End User, 2022–2028

    10.9. Market Attractiveness Analysis

        10.9.1. By Country

        10.9.2. By Excipient Type

        10.9.3. By End User

    10.10. Key Market Participants – Intensity Mapping

    10.11. Drivers and Restraints: Impact Analysis

11. Western Europe Biologic Excipients Market Analysis 2013-2021 and Forecast 2022–2028

    11.1. Introduction

    11.2. Regional Market Trends 

    11.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021

        11.3.1. Germany

        11.3.2. U.K

        11.3.3. France

        11.3.4. Italy

        11.3.5. Spain

        11.3.6. Rest of Western Europe

    11.4. Market Size (US$ Mn) Forecast By Country, 2022–2028

        11.4.1. Germany

        11.4.2. U.K

        11.4.3. France

        11.4.4. Italy

        11.4.5. Spain

        11.4.6. Rest of Western Europe

    11.5. Historical Market Size (US$ Mn) & Trend Analysis By Excipient Type, 2013-2021

        11.5.1. Polymers

        11.5.2. Sugar Alcohols

        11.5.3. Polysorbates

        11.5.4. Inorganic Salts

        11.5.5. Amino Acids

        11.5.6. Surfactants

        11.5.7. Others

    11.6. Market Size (US$ Mn) & Forecast By Excipient Type, 2022–2028

    11.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021

        11.7.1. Biopharmaceutical Manufacturers

        11.7.2. Contract Research Organizations/Contract Manufacturing Organizations

        11.7.3. Research Organizations

    11.8. Market Size (US$ Mn) Forecast By End User, 2022–2028

    11.9. Market Attractiveness Analysis

        11.9.1. By Country

        11.9.2. By Excipient Type

        11.9.3. By End User

    11.10. Key Market Participants – Intensity Mapping

    11.11. Drivers and Restraints: Impact Analysis

12. Eastern Europe Biologic Excipients Market Analysis 2013-2021 and Forecast 2022–2028

    12.1. Introduction

    12.2. Regional Market Trends

    12.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021

        12.3.1. Russia

        12.3.2. Poland

        12.3.3. Rest of Eastern Europe

    12.4. Historical Market Size (US$ Mn) & Trend Analysis By Excipient Type, 2013-2021

        12.4.1. Polymers

        12.4.2. Sugar Alcohols

        12.4.3. Polysorbates

        12.4.4. Inorganic Salts

        12.4.5. Amino Acids

        12.4.6. Surfactants

        12.4.7. Others

    12.5. Market Size (US$ Mn) & Forecast By Excipient Type, 2022–2028

    12.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021

        12.6.1. Biopharmaceutical Manufacturers

        12.6.2. Contract Research Organizations/Contract Manufacturing Organizations

        12.6.3. Research Organizations

    12.7. Market Size (US$ Mn) Forecast By End User, 2022–2028

    12.8. Market Attractiveness Analysis

        12.8.1. By Country

        12.8.2. By Excipient Type

        12.8.3. By End User

    12.9. Key Market Participants – Intensity Mapping

    12.10. Drivers and Restraints: Impact Analysis

13. Latin America Biologic Excipients Market Analysis 2013-2021 and Forecast 2022–2028

    13.1. Introduction

    13.2. Regional Market Trends

    13.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021

        13.3.1. Brazil

        13.3.2. Mexico

        13.3.3. Rest of Latin America

    13.4. Market Size (US$ Mn) Forecast By Country, 2022–2028

        13.4.1. Brazil

        13.4.2. Mexico

        13.4.3. Rest of Latin America

    13.5. Historical Market Size (US$ Mn) & Trend Analysis By Excipient Type, 2013-2021

        13.5.1. Polymers

        13.5.2. Sugar Alcohols

        13.5.3. Polysorbates

        13.5.4. Inorganic Salts

        13.5.5. Amino Acids

        13.5.6. Surfactants

        13.5.7. Others

    13.6. Market Size (US$ Mn) & Forecast By Excipient Type, 2022–2028

    13.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021

        13.7.1. Biopharmaceutical Manufacturers

        13.7.2. Contract Research Organizations/Contract Manufacturing Organizations

        13.7.3. Research Organizations

    13.8. Market Size (US$ Mn) Forecast By End User, 2022–2028

    13.9. Market Attractiveness Analysis

        13.9.1. By Country

        13.9.2. By Excipient Type

        13.9.3. By End User

    13.10. Key Market Participants – Intensity Mapping

    13.11. Drivers and Restraints: Impact Analysis

14. Asia Pacific Excluding China & Japan Biologic Excipients Market Analysis 2013-2021 and Forecast 2022–2028

    14.1. Introduction

    14.2. Regional Market Trends

    14.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021

        14.3.1. India

        14.3.2. Australia and New Zealand

        14.3.3. ASEAN

        14.3.4. Rest of APECJ

    14.4. Market Size (US$ Mn) Forecast By Country, 2022–2028

        14.4.1. India

        14.4.2. Australia and New Zealand

        14.4.3. ASEAN

        14.4.4. Rest of APECJ

    14.5. Historical Market Size (US$ Mn) & Trend Analysis By Excipient Type, 2013-2021

        14.5.1. Polymers

        14.5.2. Sugar Alcohols

        14.5.3. Polysorbates

        14.5.4. Inorganic Salts

        14.5.5. Amino Acids

        14.5.6. Surfactants

        14.5.7. Others

    14.6. Market Size (US$ Mn) & Forecast By Excipient Type, 2022–2028

    14.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021

        14.7.1. Biopharmaceutical Manufacturers

        14.7.2. Contract Research Organizations/Contract Manufacturing Organizations

        14.7.3. Research Organizations

    14.8. Market Size (US$ Mn) Forecast By End User, 2022–2028

    14.9. Market Attractiveness Analysis

        14.9.1. By Country

        14.9.2. By Excipient Type

        14.9.3. By End User

    14.10. Key Market Participants – Intensity Mapping

    14.11. Drivers and Restraints: Impact Analysis

15. China Biologic Excipients Market Analysis 2013-2021 and Forecast 2022–2028

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) & Trend Analysis By Excipient Type, 2013-2021

        15.2.1. Polymers

        15.2.2. Sugar Alcohols

        15.2.3. Polysorbates

        15.2.4. Inorganic Salts

        15.2.5. Amino Acids

        15.2.6. Surfactants

        15.2.7. Others

    15.3. Market Size (US$ Mn) & Forecast By Excipient Type, 2022–2028

    15.4. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021

        15.4.1. Biopharmaceutical Manufacturers

        15.4.2. Contract Research Organizations/Contract Manufacturing Organizations

        15.4.3. Research Organizations

    15.5. Market Size (US$ Mn) Forecast By End User, 2022–2028

    15.6. Market Attractiveness Analysis

        15.6.1. By Excipient Type

        15.6.2. By End User

    15.7. Key Market Participants – Intensity Mapping

    15.8. Drivers and Restraints: Impact Analysis

16. Japan Biologic Excipients Market Analysis 2013-2021 and Forecast 2022–2028

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) & Trend Analysis By Excipient Type, 2013-2021

        16.2.1. Polymers

        16.2.2. Sugar Alcohols

        16.2.3. Polysorbates

        16.2.4. Inorganic Salts

        16.2.5. Amino Acids

        16.2.6. Surfactants

        16.2.7. Others

    16.3. Market Size (US$ Mn) & Forecast By Excipient Type, 2022–2028

    16.4. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021

        16.4.1. Biopharmaceutical Manufacturers

        16.4.2. Contract Research Organizations/Contract Manufacturing Organizations

        16.4.3. Research Organizations

    16.5. Market Size (US$ Mn) Forecast By End User, 2022–2028

    16.6. Market Attractiveness Analysis

        16.6.1. By Excipient Type

        16.6.2. By End User

    16.7. Key Market Participants – Intensity Mapping

    16.8. Drivers and Restraints: Impact Analysis

17. Middle East and Africa Biologic Excipients Market Analysis 2013-2021 and Forecast 2022–2028

    17.1. Introduction

    17.2. Regional Market Trends

    17.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021

        17.3.1. GCC Countries

        17.3.2. South Africa

        17.3.3. Rest of MEA

    17.4. Market Size (US$ Mn) Forecast By Country, 2022–2028

        17.4.1. GCC Countries

        17.4.2. South Africa

        17.4.3. Rest of MEA

    17.5. Historical Market Size (US$ Mn) & Trend Analysis By Excipient Type, 2013-2021

        17.5.1. Polymers

        17.5.2. Sugar Alcohols

        17.5.3. Polysorbates

        17.5.4. Inorganic Salts

        17.5.5. Amino Acids

        17.5.6. Surfactants

        17.5.7. Others

    17.6. Market Size (US$ Mn) & Forecast By Excipient Type, 2022–2028

    17.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021

        17.7.1. Biopharmaceutical Manufacturers

        17.7.2. Contract Research Organizations/Contract Manufacturing Organizations

        17.7.3. Research Organizations

    17.8. Market Size (US$ Mn) Forecast By End User, 2022–2028

    17.9. Market Attractiveness Analysis

        17.9.1. By Country

        17.9.2. By Excipient Type

        17.9.3. By End User

    17.10. Key Market Participants – Intensity Mapping

    17.11. Drivers and Restraints: Impact Analysis

18. Forecast Factors: Relevance and Impact

19. Forecast Assumptions

20. Competition Analysis

    20.1. Competition Dashboard

    20.2. Competition Benchmarking

    20.3. Competitors Deep Dive

        20.3.1. Roquette Frères

            20.3.1.1. Overview

            20.3.1.2. Product  and Application Portfolio

            20.3.1.3. Production  Footprint

            20.3.1.4. Sales Footprint

            20.3.1.5. Channel Footprint

            20.3.1.6. Strategy

                    20.3.1.6.1.1. Marketing Strategy

                    20.3.1.6.1.2. Product Strategy

                    20.3.1.6.1.3. Channel Strategy

        20.3.2. The Dow Chemical Company 

            20.3.2.1. Overview

            20.3.2.2. Product  and Application Portfolio

            20.3.2.3. Production Footprint

            20.3.2.4. Sales Footprint

            20.3.2.5. Channel Footprint

            20.3.2.6. Strategy

                    20.3.2.6.1.1. Marketing Strategy

                    20.3.2.6.1.2. Product Strategy

                    20.3.2.6.1.3. Channel Strategy

        20.3.3. FMC Corporation 

            20.3.3.1. Overview

            20.3.3.2. Product  and Application Portfolio

            20.3.3.3. Production  Footprint

            20.3.3.4. Sales Footprint

            20.3.3.5. Channel Footprint

            20.3.3.6. Strategy

                    20.3.3.6.1.1. Marketing Strategy

                    20.3.3.6.1.2. Product Strategy

                    20.3.3.6.1.3. Channel Strategy

        20.3.4. Ashland Inc. 

            20.3.4.1. Overview

            20.3.4.2. Product  and Application Portfolio

            20.3.4.3. Production  Footprint

            20.3.4.4. Sales Footprint

            20.3.4.5. Channel Footprint

            20.3.4.6. Strategy

                    20.3.4.6.1.1. Marketing Strategy

                    20.3.4.6.1.2. Product Strategy

                    20.3.4.6.1.3. Channel Strategy

        20.3.5. Signet Chemical Corporation Pvt. Ltd. 

            20.3.5.1. Overview

            20.3.5.2. Product  and Application Portfolio

            20.3.5.3. Production  Footprint

            20.3.5.4. Sales Footprint

            20.3.5.5. Channel Footprint

            20.3.5.6. Strategy

                    20.3.5.6.1.1. Marketing Strategy

                    20.3.5.6.1.2. Product Strategy

                    20.3.5.6.1.3. Channel Strategy

        20.3.6. BASF Corporation

            20.3.6.1. Overview

            20.3.6.2. Product  and Application Portfolio

            20.3.6.3. Production  Footprint

            20.3.6.4. Sales Footprint

            20.3.6.5. Channel Footprint

            20.3.6.6. Strategy

                    20.3.6.6.1.1. Marketing Strategy

                    20.3.6.6.1.2. Product Strategy

                    20.3.6.6.1.3. Channel Strategy

        20.3.7. Colorcon

            20.3.7.1. Overview

            20.3.7.2. Product  and Application Portfolio

            20.3.7.3. Production  Footprint

            20.3.7.4. Sales Footprint

            20.3.7.5. Channel Footprint

            20.3.7.6. Strategy

                    20.3.7.6.1.1. Marketing Strategy

                    20.3.7.6.1.2. Product Strategy

                    20.3.7.6.1.3. Channel Strategy

        20.3.8. The Archer Daniels Midland Company

            20.3.8.1. Overview

            20.3.8.2. Product  and Application Portfolio

            20.3.8.3. Production  Footprint

            20.3.8.4. Sales Footprint

            20.3.8.5. Channel Footprint

            20.3.8.6. Strategy

                    20.3.8.6.1.1. Marketing Strategy

                    20.3.8.6.1.2. Product Strategy

                    20.3.8.6.1.3. Channel Strategy

        20.3.9. Wacker Chemie AG

            20.3.9.1. Overview

            20.3.9.2. Product and Application Portfolio

            20.3.9.3. Production  Footprint

            20.3.9.4. Sales Footprint

            20.3.9.5. Channel Footprint

            20.3.9.6. Strategy

                    20.3.9.6.1.1. Marketing Strategy

                    20.3.9.6.1.2. Product Strategy

                    20.3.9.6.1.3. Channel Strategy

        20.3.10. DuPont

            20.3.10.1. Overview

            20.3.10.2. Product  and Application Portfolio

            20.3.10.3. Production  Footprint

            20.3.10.4. Sales Footprint

            20.3.10.5. Channel Footprint

            20.3.10.6. Strategy

                    20.3.10.6.1.1. Marketing Strategy

                    20.3.10.6.1.2. Product Strategy

                    20.3.10.6.1.3. Channel Strategy

        20.3.11. Evonik Industries

            20.3.11.1. Overview

            20.3.11.2. Product  and Application Portfolio

            20.3.11.3. Production  Footprint

            20.3.11.4. Sales Footprint

            20.3.11.5. Channel Footprint

            20.3.11.6. Strategy

                    20.3.11.6.1.1. Marketing Strategy

                    20.3.11.6.1.2. Product Strategy

                    20.3.11.6.1.3. Channel Strategy

21. Global Biologic Excipients Market Analysis 2013-2021 and Forecast 2022–2028 By Region

    21.1. Introduction / Key Findings

    21.2. Historical Market Size (US$ Mn) Analysis By Region

        21.2.1. North America

        21.2.2. Western Europe

        21.2.3. Eastern Europe

        21.2.4. Latin America

        21.2.5. Asia Pacific Excluding Japan And China

        21.2.6. China

        21.2.7. Japan

        21.2.8. Middle East and Africa

    21.3. Market Size (US$ Mn) Forecast By Region

        21.3.1. North America

        21.3.2. Western Europe

        21.3.3. Eastern Europe

        21.3.4. Latin America

        21.3.5. Asia Pacific Excluding Japan And China

        21.3.6. China

        21.3.7. Japan

        21.3.8. Middle East and Africa

    21.4. Market Attractiveness Analysis By Region

22. Global Biologic Excipients Market Analysis 2013-2021 and Forecast 2022–2028, By Excipient Type

    22.1. Introduction/Key Finding

    22.2. Historical Market Size (US$ Mn) & Trend Analysis By Excipient Type, 2013-2021

        22.2.1. Polymers

        22.2.2. Sugar Alcohols

        22.2.3. Polysorbates

        22.2.4. Inorganic Salts

        22.2.5. Amino Acids

        22.2.6. Surfactants

        22.2.7. Others

    22.3. Market Size (US$ Mn) & Forecast By Excipient Type, 2022–2028

    22.4. Market Attractiveness Analysis By Excipient Type

23. Global Biologic Excipients Market Analysis 2013-2021 and Forecast 2022–2028, By End User

    23.1. Introduction/Key Finding

    23.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021

        23.2.1. Biopharmaceutical Manufacturers

        23.2.2. Contract Research Organizations/Contract Manufacturing Organizations

        23.2.3. Research Organizations

    23.3. Market Size (US$ Mn) Forecast By End User, 2022–2028

24. Global Biologic Excipients Market Analysis 2013-2021 and Forecast 2022–2028

    24.1. Market Value Share Analysis By All Segment

    24.2. Y-o-Y Growth Analysis By All Segment

    24.3. Absolute $ Opportunity

25. Assumptions and Acronyms Used

26. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: List of Commercial Monoclonal Antibody Products and their Excipients, By Company

Table 02: Frequency of Excipient Inclusion in MAb Formulations (%)

Table 03: Excipient Composition, By Monoclonal Antibody (MAb)

Table 04: Excipient Composition, By Insulin

Table 05: Excipient Composition, By Human Growth Hormone (HGH)

Table 06: Excipient Composition, By Interferon (INF)

Table 07: Excipient Composition, By Granulocyte-Colony Stimulating Factors (G-CSFs)

Table 08: North America Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Country

Table 09: North America Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Excipient

Table 10: North America Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By End User

Table 11: Latin America Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Country

Table 12: Latin America Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Excipient

Table 13: Latin America Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By End User

Table 14: Western Europe Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Country

Table 15: Western Europe Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Excipient

Table 16: Western Europe Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By End User

Table 17: Eastern Europe Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Country

Table 18: Eastern Europe Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Excipient

Table 19: Eastern Europe Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By End User

Table 20: APECJ Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Country

Table 21: APECJ Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Excipient

Table 22: APECJ Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By End User

Table 23: Japan Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Excipient

Table 24: Japan Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By End User

Table 25: China Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Excipient

Table 26: China Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By End User

Table 27: MEA Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Country

Table 28: MEA Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Excipient

Table 29: MEA Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By End User

Table 30: Global Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Region

Table 31: Global Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Excipient

Table 32: Global Biologic Excipients Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By End User

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Market Value Share 2022E, By Excipient Type

Figure 02: Global Biologic Excipients Market Revenue Opportunity Analysis, By Country 2018-2028

Figure 03: Global Biologic Excipients Market, 2021A

Figure 04: GDP (US$ Trillion) and Healthcare Expenditure % (2020)

Figure 05: Global Healthcare Expenditure in US$ Tn (2013–2020)

Figure 05: Global Healthcare Expenditure in US$ Tn (2013–2020)

Figure 06: North America Biologic Excipients Market Value Share, By Excipient Type (2021A)

Figure 07: North America Biologic Excipients Market Value Share (2021A), By End User

Figure 08: North America Biologic Excipients Market Value Share (2021A), By Country

Figure 09: North America Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 10: North America Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 11: U.S. Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 12: U.S. Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 13: Canada Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 14: Canada Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 15: North America Polymers Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 16: North America Polymers Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 17: North America Sugar Alcohols Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 18: North America Sugar Alcohols Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 19: North America Polysorbates Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 20: North America Polysorbates Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 21: North America Inorganic Salts Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 22: North America Inorganic Salts Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 23: North America Amino Acids Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 24: North America Amino Acids Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 25: North America Surfactants Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 26: North America Surfactants Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 27: North America Other Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 28: North America Other Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 29: North America Biopharmaceutical Manufacturers Market size (US$ Mn) Analysis, 2013–2021

Figure 30: North America Biopharmaceutical Manufacturers Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 31: North America Contract Research Organizations/Contract Manufacturing Organizations Market size (US$ Mn) Analysis, 2013–2021

Figure 32: North America CROs/CMOs Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 33: North America Research Organizations Market size (US$ Mn) Analysis, 2013–2021

Figure 34: North America Research Organizations Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 35: North America Biologic Excipients Market Attractiveness Analysis, By Excipient Type

Figure 36: North America Biologic Excipients Market Attractiveness Analysis, By End User

Figure 37: North America Biologic Excipients Market Attractiveness Analysis, By Country

Figure 38: Latin America Biologic Excipients Market Value Share, By Excipient Type (2021A)

Figure 39: Latin America Biologic Excipients Market Value Share (2021A), By End User

Figure 40: Latin America Biologic Excipients Market Value Share (2021A), By Country

Figure 41: Latin America Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 42: Latin America Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 43: Brazil Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 44: Brazil Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 45: Mexico Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 46: Mexico Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 47: Rest of Latin America Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 48: Rest of Latin America Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 49: Latin America Polymers Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 50: Latin America Polymers Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 51: Latin America Sugar Alcohols Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 52: Latin America Sugar Alcohols Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 53: Latin America Polysorbates Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 54: Latin America Polysorbates Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 55: Latin America Inorganic Salts Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 56: Latin America Inorganic Salts Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 57: Latin America Amino Acids Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 58: Latin America Amino Acids Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 59: Latin America Surfactants Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 60: Latin America Surfactants Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 61: Latin America Other Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 62: Latin America Other Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 63: Latin America Biopharmaceutical Manufacturers Market size (US$ Mn) Analysis, 2013–2021

Figure 64: Latin America Biopharmaceutical Manufacturers Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 65: Latin America Contract Research Organizations/Contract Manufacturing Organizations Market size (US$ Mn) Analysis, 2013–2021

Figure 66: Latin America CROs/CMOs Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 67: Latin America Research Organizations Market size (US$ Mn) Analysis, 2013–2021

Figure 68: Latin America Research Organizations Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 69: Latin America Biologic Excipients Market Attractiveness Analysis, By Excipient Type

Figure 70: Latin America Biologic Excipients Market Attractiveness Analysis, By End User

Figure 71: Latin America Biologic Excipients Market Attractiveness Analysis, By Country

Figure 72: Western Europe Biologic Excipients Market Value Share, By Excipient Type (2021A)

Figure 73: Western Europe Biologic Excipients Market Value Share (2021A), By End User

Figure 74: Western Europe Biologic Excipients Market Value Share (2021A), By Country

Figure 75: Western Europe Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 76: Western Europe Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 77: Germany Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 78: Germany Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 79: Spain Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 80: Spain Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 81: U.K Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 82: U.K Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 83: Italy Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 84: Italy Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 85: France Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 86: France Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 87: Rest of Europe Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 88: Rest of Europe Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 89: Western Europe Polymers Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 90: Western Europe Polymers Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 91: Western Europe Sugar Alcohols Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 92: Western Europe Sugar Alcohols Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 93: Western Europe Polysorbates Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 94: Western Europe Polysorbates Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 95: Western Europe Inorganic Salts Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 96: Western Europe Inorganic Salts Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 97: Western Europe Amino Acids Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 98: Western Europe Amino Acids Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 99: Western Europe Surfactants Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 100: Western Europe Surfactants Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 101: Western Europe Other Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 102: Western Europe Other Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 103: Western Europe Biopharmaceutical Manufacturers Market size (US$ Mn) Analysis, 2013–2021

Figure 104: Western Europe Biopharmaceutical Manufacturers Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 105: Western Europe Contract Research Organizations/Contract Manufacturing Organizations Market size (US$ Mn) Analysis, 2013–2021

Figure 106: Western Europe CROs/CMOs Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 107: Western Europe Research Organizations Market size (US$ Mn) Analysis, 2013–2021

Figure 108: Western Europe Research Organizations Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 109: Western Europe Biologic Excipients Market Attractiveness Analysis, By Excipient Type

Figure 110: Western Europe Biologic Excipients Market Attractiveness Analysis, By End User

Figure 111: Western Europe Biologic Excipients Market Attractiveness Analysis, By Country

Figure 112: Eastern Europe Biologic Excipients Market Value Share, By Excipient Type (2021A)

Figure 113: Eastern Europe Biologic Excipients Market Value Share (2021A), By End User

Figure 114: Eastern Europe Biologic Excipients Market Value Share (2021A), By Country

Figure 115: Eastern Europe Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 116: Eastern Europe Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 117: Russia Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 118: Russia Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 119: Poland Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 120: Poland Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 121: Rest of Eastern Europe Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 122: Rest of Eastern Europe Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 123: Eastern Europe Polymers Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 124: Eastern Europe Polymers Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 125: Eastern Europe Sugar Alcohols Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 126: Eastern Europe Sugar Alcohols Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 127: Eastern Europe Polysorbates Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 128: Eastern Europe Polysorbates Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 129: Eastern Europe Inorganic Salts Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 130: Eastern Europe Inorganic Salts Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 131: Eastern Europe Amino Acids Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 132: Eastern Europe Amino Acids Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 133: Eastern Europe Surfactants Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 134: Eastern Europe Surfactants Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 135: Eastern Europe Other Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 136: Eastern Europe Other Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 137: Eastern Europe Biopharmaceutical Manufacturers Market size (US$ Mn) Analysis, 2013–2021

Figure 138: Eastern Europe Biopharmaceutical Manufacturers Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 139: Eastern Europe Contract Research Organizations/Contract Manufacturing Organizations Market size (US$ Mn) Analysis, 2013–2021

Figure 140: Eastern Europe CROs/CMOs Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 141: Eastern Europe Research Organizations Market size (US$ Mn) Analysis, 2013–2021

Figure 142: Eastern Europe Research Organizations Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 143: Eastern Europe Biologic Excipients Market Attractiveness Analysis, By Excipient Type

Figure 144: Eastern Europe Biologic Excipients Market Attractiveness Analysis, By End User

Figure 145: Eastern Europe Biologic Excipients Market Attractiveness Analysis, By Country

Figure 146: APECJ Biologic Excipients Market Value Share, By Excipient Type (2021A)

Figure 147: APECJ Biologic Excipients Market Value Share (2021A), By End User

Figure 148: APECJ Biologic Excipients Market Value Share (2021A), By Country

Figure 149: APECJ Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 150: APECJ Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 151: India Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 152: India Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 153: Australia & New Zealand Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 154: Australia & New Zealand Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 155: ASEAN Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 156: ASEAN Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 157: Rest of APECJ Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 158: Rest of APECJ Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 159: APECJ Polymers Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 160: APECJ Polymers Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 161: APECJ Sugar Alcohols Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 162: APECJ Sugar Alcohols Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 163: APECJ Polysorbates Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 164: APECJ Polysorbates Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 165: APECJ Inorganic Salts Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 166: APECJ Inorganic Salts Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 167: APECJ Amino Acids Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 168: APECJ Amino Acids Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 169: APECJ Surfactants Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 170: APECJ Surfactants Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 171: APECJ Other Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 172: APECJ Other Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 173: APECJ Biopharmaceutical Manufacturers Market size (US$ Mn) Analysis, 2013–2021

Figure 174: APECJ Biopharmaceutical Manufacturers Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 175: APECJ Contract Research Organizations/Contract Manufacturing Organizations Market size (US$ Mn) Analysis, 2013–2021

Figure 176: APECJ CROs/CMOs Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 177: APECJ Research Organizations Market size (US$ Mn) Analysis, 2013–2021

Figure 178: APECJ Research Organizations Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 179: APECJ Biologic Excipients Market Attractiveness Analysis, By Excipient Type

Figure 180: APECJ Biologic Excipients Market Attractiveness Analysis, By End User

Figure 181: APECJ Biologic Excipients Market Attractiveness Analysis, By Country

Figure 182: Japan Biologic Excipients Market Value Share, By Excipient Type (2021A)

Figure 183: Japan Biologic Excipients Market Value Share (2021A), By End User

Figure 184: Japan Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 185: Japan Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 186: Japan Polymers Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 187: Japan Polymers Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 188: Japan Sugar Alcohols Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 189: Japan Sugar Alcohols Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 190: Japan Polysorbates Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 191: Japan Polysorbates Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 192: Japan Inorganic Salts Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 193: Japan Inorganic Salts Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 194: Japan Amino Acids Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 195: Japan Amino Acids Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 196: Japan Surfactants Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 197: Japan Surfactants Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 198: Japan Other Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 199: Japan Other Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 200: Japan Biopharmaceutical Manufacturers Market size (US$ Mn) Analysis, 2013–2021

Figure 201: Japan Biopharmaceutical Manufacturers Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 202: Japan Contract Research Organizations/Contract Manufacturing Organizations Market size (US$ Mn) Analysis, 2013–2021

Figure 203: Japan CROs/CMOs Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 204: Japan Research Organizations Market size (US$ Mn) Analysis, 2013–2021

Figure 205: Japan Research Organizations Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 206: Japan Biologic Excipients Market Attractiveness Analysis, By Excipient Type

Figure 207: Japan Biologic Excipients Market Attractiveness Analysis, By End User

Figure 208: China Biologic Excipients Market Value Share, By Excipient Type (2021A)

Figure 209: China Biologic Excipients Market Value Share (2021A), By End User

Figure 210: China Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 211: China Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 212: China Polymers Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 213: China Polymers Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 214: China Sugar Alcohols Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 215: China Sugar Alcohols Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 216: China Polysorbates Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 217: China Polysorbates Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 218: China Inorganic Salts Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 219: China Inorganic Salts Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 220: China Amino Acids Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 221: China Amino Acids Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 222: China Surfactants Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 223: China Surfactants Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 224: China Other Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 225: China Other Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 226: China Biopharmaceutical Manufacturers Market size (US$ Mn) Analysis, 2013–2021

Figure 227: China Biopharmaceutical Manufacturers Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 228: China Contract Research Organizations/Contract Manufacturing Organizations Market size (US$ Mn) Analysis, 2013–2021

Figure 229: China CROs/CMOs Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 230: China Research Organizations Market size (US$ Mn) Analysis, 2013–2021

Figure 231: China Research Organizations Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 232: China Biologic Excipients Market Attractiveness Analysis, By Excipient Type

Figure 233: China Biologic Excipients Market Attractiveness Analysis, By End User

Figure 234: MEA Biologic Excipients Market Value Share, By Excipient Type (2021A)

Figure 235: MEA Biologic Excipients Market Value Share (2021A), By End User

Figure 236: MEA Biologic Excipients Market Value Share (2021A), By Country

Figure 237: MEA Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 238: MEA Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 239: GCC Countries Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 240: GCC Countries Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 241: South Africa Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 242: South Africa Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 243: Rest of MEA Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 244: Rest of MEA Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 245: MEA Polymers Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 246: MEA Polymers Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 247: MEA Sugar Alcohols Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 248: MEA Sugar Alcohols Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 249: MEA Polysorbates Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 250: MEA Polysorbates Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 251: MEA Inorganic Salts Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 252: MEA Inorganic Salts Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 253: MEA Amino Acids Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 254: MEA Amino Acids Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 255: MEA Surfactants Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 256: MEA Surfactants Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 257: MEA Other Biologic Excipients Market size (US$ Mn) Analysis, 2013–2021

Figure 258: MEA Other Biologic Excipients Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 259: MEA Biopharmaceutical Manufacturers Market size (US$ Mn) Analysis, 2013–2021

Figure 260: MEA Biopharmaceutical Manufacturers Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 261: MEA Contract Research Organizations/Contract Manufacturing Organizations Market size (US$ Mn) Analysis, 2013–2021

Figure 262: MEA CROs/CMOs Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 263: MEA Research Organizations Market size (US$ Mn) Analysis, 2013–2021

Figure 264: MEA Research Organizations Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 265: MEA Biologic Excipients Market Attractiveness Analysis, By Excipient Type

Figure 266: MEA Biologic Excipients Market Attractiveness Analysis, By End User

Figure 267: MEA Biologic Excipients Market Attractiveness Analysis, By Country

Figure 268: Global Biologic Excipients Market Share Analysis (%) By Region, 2022 & 2028

Figure 269: Global Biologic Excipients Market Y-o-Y Growth (%) By Region, 2022–2028

Figure 270: Global Biologic Excipients Market Attractiveness Analysis By Region, 2022–2028

Figure 271: Global Biologic Excipients Market Share Analysis (%) By Excipient, 2022 & 2028

Figure 272: Global Biologic Excipients Market Y-o-Y Growth (%) By Excipient, 2022–2028

Figure 273: Global Biologic Excipients Market Attractiveness Analysis By Excipient, 2022–2028

Figure 274: Global Biologic Excipients Market Share Analysis (%) By End User, 2022 & 2028

Figure 275: Global Biologic Excipients Market Y-o-Y Growth (%) By End User, 2022–2028

Figure 276: Global Biologic Excipients Market Attractiveness Analysis By End User, 2022–2028

Figure 277: Global Biologic Excipients Market Value Analysis and Forecast, 2021–2028 (US$ Mn)

Figure 278: Global Biologic Excipients Market Value (US$ Mn), 2013–2021

Figure 279: Global Biologic Excipients Market Absolute $ Opportunity (US$ Mn), 2021–2028

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Sustained Release Excipients Market

Published : November 2018

Healthcare

Biologic Excipients Market

Published : February 2022

Healthcare

Pharmaceuticals Excipients Market

Published : March 2022

Healthcare

Orthobiologics Market

Published : January 2022

Google translate

Biologic Excipients Market